Your browser doesn't support javascript.
loading
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma.
Brunelli, Matteo; Tafuri, Alessandro; Cima, Luca; Cerruto, Maria Angela; Milella, Michele; Zivi, Andrea; Buti, Sebastiano; Bersanelli, Melissa; Fornarini, Giuseppe; Vellone, Valerio Gaetano; Rebuzzi, Sara Elena; Procopio, Giuseppe; Verzoni, Elena; Bracarda, Sergio; Sabbatini, Roberto; Baldessari, Cinzia; Eccher, Albino; Passalacqua, Rodolfo; Perrucci, Bruno; Giganti, Maria Olga; Donini, Maddalena; Panni, Stefano; Tucci, Marcello; Prati, Veronica; Ortega, Cinzia; Caliò, Anna; Alongi, Filippo; Munari, Enrico; Pappagallo, Giovanni; Iacovelli, Roberto; Mosca, Alessandra; Porta, Camillo; Martignoni, Guido; Antonelli, Alessandro.
Affiliation
  • Brunelli M; Department of Diagnostics and Public Health, Pathology Unit, University and Hospital Trust of Verona, Verona, Italy matteo.brunelli@univr.it.
  • Tafuri A; Department of Diagnostics and Public Health, FISH Lab, University and Hospital Trust of Verona, Verona, Italy.
  • Cima L; Division of Urology, University and Hospital Trust of Verona, Verona, Italy.
  • Cerruto MA; Department of Clinical Services, Pathology Unit, Santa Chiara Hospital, Trento, Italy.
  • Milella M; Division of Urology, University and Hospital Trust of Verona, Verona, Italy.
  • Zivi A; Division of Oncology, University and Hospital Trust of Verona, Verona, Italy.
  • Buti S; Division of Oncology, University and Hospital Trust of Verona, Verona, Italy.
  • Bersanelli M; Division of Oncology, University and Hospital Trust of Parma, Parma, Italy.
  • Fornarini G; Division of Oncology, University and Hospital Trust of Parma, Parma, Italy.
  • Vellone VG; Division of Oncology, San Martino Hospital, Genova, Italy.
  • Rebuzzi SE; Division of Oncology, San Martino Hospital, Genova, Italy.
  • Procopio G; Division of Oncology, San Martino Hospital, Genova, Italy.
  • Verzoni E; Division of Oncology, IRCCS Foundation, Istituto Nazionale dei Tumori di Milano, Milano, Italy.
  • Bracarda S; Division of Oncology, IRCCS Foundation, Istituto Nazionale dei Tumori di Milano, Milano, Italy.
  • Sabbatini R; Division of Oncology, Santa Maria Hospital, Terni, Italy.
  • Baldessari C; Department of Oncology, Hematology & Respiratory Diseases, Division of Oncology, University of Modena & Reggio Emilia, Modena, Modena & Reggio Emilia, Italy.
  • Eccher A; Department of Oncology, Hematology & Respiratory Diseases, Division of Oncology, University of Modena & Reggio Emilia, Modena, Modena & Reggio Emilia, Italy.
  • Passalacqua R; Department of Diagnostics and Public Health, Pathology Unit, University and Hospital Trust of Verona, Verona, Italy.
  • Perrucci B; Division of Oncology, Hospital Trust of Cremona, Cremona, Italy.
  • Giganti MO; Division of Oncology, Hospital Trust of Cremona, Cremona, Italy.
  • Donini M; Division of Oncology, Hospital Trust of Cremona, Cremona, Italy.
  • Panni S; Division of Oncology, Hospital Trust of Cremona, Cremona, Italy.
  • Tucci M; Division of Oncology, Hospital Trust of Cremona, Cremona, Italy.
  • Prati V; Division of Oncology, Cardinal Massaia Hospital, Asti, Italy.
  • Ortega C; Division of Oncology, Institute for Cancer Research and Treatment, Asl Cn2 Alba-Brà, Alba-Brà, Italy.
  • Caliò A; Division of Oncology, Institute for Cancer Research and Treatment, Asl Cn2 Alba-Brà, Alba-Brà, Italy.
  • Alongi F; Department of Diagnostics and Public Health, Pathology Unit, University and Hospital Trust of Verona, Verona, Italy.
  • Munari E; Division of Radiotherapy, Ospedale SacroCuore di Negrar di Valpolicella, Negrar, Italy.
  • Pappagallo G; Division of Pathology, Ospedale SacroCuore di Negrar di Valpolicella, Negrar, Italy.
  • Iacovelli R; Clinical Epidemiologist, Silea, Italy.
  • Mosca A; Policlinico Universitario Fondazione Andrea Gemelli, Rome, Italy.
  • Porta C; Oncology, Candiolo Cancer Institute, IRCCS-FPO, Torino, Italy.
  • Martignoni G; Department of Biomedical Sciences and Human Oncology, University of Bari 'A.Moro', Bari, Italy.
  • Antonelli A; Division of Medical Oncology, Policlinico Consorziale di Bari, Bari, Italy.
J Clin Pathol ; 75(1): 39-44, 2022 Jan.
Article in En | MEDLINE | ID: mdl-33144356

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Proto-Oncogene Proteins c-mdm2 / B7-H1 Antigen Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pathol Year: 2022 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Proto-Oncogene Proteins c-mdm2 / B7-H1 Antigen Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pathol Year: 2022 Type: Article Affiliation country: Italy